Dr. Iliyan D. Iliev, an associate professor of immunology in medicine in the Division of Gastroenterology and Hepatology, co-director of the Microbiome Core and a member of the Jill Roberts Institute for Research in Inflammatory Bowel Disease (IBD) at Weill Cornell Medicine, is the lead investigator on a grant to Weill Cornell Medicine from The Leona M. and Harry B. Helmsley Charitable Trust to target pathogenic fungi in patients with Crohn’s disease.
DEA Opens Cannabis Rescheduling Comment Period
The Drug Enforcement Administration published its proposed rescheduling of cannabis today. There is a comment period that ends on July 22nd. The biggest outcome of
May 21, 2024